Overview

Bioequivalence and Food Effect Study in Healthy Volunteers

Status:
Completed

Trial end date:
2007-09-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to select the formulation with the optimal pharmacokinetic profile for an hypnotic drug to further develop in the market.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline